Capturing the attention of US investors requires “thinking unicorn”
Sean Kendall, Partner at ARCH Venture Partners, shared his INSIGHTS on how to succeed in fundraising from US investors.
Do you know:
How to pitch US investors in a way that makes them lean in—not tune out?
What signals US investors look for in early-stage European life science ventures?
When it makes sense to build a US presence—and what you need in place before you do?
How you should think about valuation, equity, and team incentives if you’re aiming for long-term US backing?
What’s holding European life science ventures back globally—and how can you avoid those traps?
If you want to learn more, apply to join here.
Previous